European Union Orders Extra BioNTech-Pfizer Vaccines Amid J&J Suspension
April 14 2021 - 9:11AM
Dow Jones News
By Daniel Michaels
The European Union, grappling with the potential loss of Johnson
& Johnson Covid-19 vaccines, will buy an additional 50 million
doses from BioNTech and Pfizer Inc. for the quarter, and is in
talks to purchase up to 1.8 billion more doses over the next two
years.
European Commission President Ursula von der Leyen said the new
order would bring total deliveries of the BioNTech-Pfizer vaccine
for the quarter to 250 million doses. The EU also expects 35
million doses from Moderna Inc. and 70 million doses from
AstraZeneca PLC during that period.
J&J had been expected to deliver 55 million doses during the
quarter, but that is now in question after the company said this
week it would delay the rollout of its vaccine in Europe due to
concerns about possible links to rare blood clots.
J&J's vaccine requires only one shot, compared with two
shots for all the others, so its deliveries had represented an even
larger proportion of total effective vaccinations. Before
Wednesday's announcement of new BioNTech-Pfizer deliveries, the
J&J shots had accounted for between 15% and 25% of
current-quarter vaccinations.
Write to Daniel Michaels at daniel.michaels@wsj.com
(END) Dow Jones Newswires
April 14, 2021 08:56 ET (12:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
